AVE 0.00% 0.3¢ avecho biotechnology limited

patent issued aug 30 2011

  1. 14,833 Posts.
    lightbulb Created with Sketch. 893
    Thes patents were issured to Vital Health Sciences which are 100% owned by Phosphagenics

    Dermal therapy using phosphate derivatives of electron transfer agents
    8008345 Dermal therapy using phosphate derivatives of electron transfer agents
    Patent Drawings:

    Inventor: West, et al.
    Date Issued: August 30, 2011
    Application: 10/485,196
    Filed: July 26, 2002
    Inventors: West; Simon Michael (Williamstown, AU)
    Verdicchio; Robert J. (Succasunna, NJ)
    Kannar; David (Belgrave South, AU)
    Mills, Jr.; Otto H. (Doylestown, PA)
    Assignee: Vital Health Sciences Pty. Ltd. (Melbourne, AU)

    here are some other patents that were issued to


    Vital Health Sciences Pty. Ltd. Patents
    Assignee:
    Vital Health Sciences Pty. Ltd.
    Address:
    Melbourne, AU
    No. of patents:
    3
    Patents:

    7648710 Formulation containing phosphate derivatives of electron transfer agents January 19, 2010
    There is provided an emulsion composition for therapeutic administration comprising: (a) at least one mono-electron transfer agent phosphate derivative; (b) at leas tone di-electron transfer agent phosphate derivative; wherein the amount of mono-electron transfer agent phosphate deri
    6579995 Process for phosphorylation and compounds produced by this process June 17, 2003
    The present invention is directed to improved processes for phosphorylation and compounds produced by the improved processes. The improved process for phosphorylating complex alcohols comprises the following steps: (a) forming an intimate mixture of one or more complex alcohols and P.sub


    some more,http://www.faqs.org/patents/assignee/vital-health-sciences-pty-ltd/

    VITAL HEALTH SCIENCES PTY. LTD.
    VITAL HEALTH SCIENCES PTY. LTD. Patent applications
    Patent application number Title Published
    20110003774 COMPOUNDS HAVING ANTI-PROLIFERATIVE PROPERTIES - There is provided a method of inhibiting the occurrence of one of more of the following conditions:—the proliferation of monocytes/macrophages; or—the proliferation of smooth muscle cells; or—the expression of CD36 receptors; or—the uptake of oxidized LDL, the method comprising the step of administering an effective amount of one or more phosphate derivatives of one or more electron transfer agents. 01-06-2011
    20090186856 MICRONUTRIENT PHOSPHATES AS DIETARY AND HEALTH SUPPLEMENTS - There is provided a dietary or health supplement comprising an effective amount of a micronutrient selected from the group consisting of phosphate derivatives of tocopherol, ubiquinol, ascorbic acid, tocotrienol, retinol and mixtures thereof delivered with an acceptable carrier. 07-23-2009
    20090005348 Compounds Having Cytokine Modulating Properties - A method of modulating one or more immuno-regulatory cytokines, such as pro-inflammatory and/or anti-inflammatory cytokines, comprising administering to a subject a therapeutically effective amount of one or more phosphate derivatives of one or more hydroxy chromans, or complexes thereof. 01-01-2009

    and this,http://www.allbusiness.com/medicine-health/diseases-disorders-cancer/15969346-1.html

    Vital Health Sciences Pty. Ltd Files Patent Application for Compounds Having Anti-Cancer Properties.

    New Delhi, April 21 -- Australia based Vital Health Sciences Pty. Ltd filed patent application for compounds having anti-cancer properties. The inventors are West Simon Michael, Ogru Esra and Gianello Robert.

    Vital Health Sciences Pty. Ltd filed the patent application on Aug. 10, 2007. The patent application number is 2943/KOLNP/2007 A. The international classification number is A61K31/353.

    According to the Controller General of Patents, Designs & Trade Marks, "There is provided a method for alleviating symptoms, treating or preventing cancer, the method comprising administering to a subject, having or at risk of developing cancer, a pharmaceutical formulation comprising an effective amount of one or more phosphate derivatives of one or more hydroxy chromans selected from the group consisting of 7:8 dimethyl 6 hydroxy chromans, 8 methyl 6 hydroxy chromans and mixtures thereof."

    this is the latest on the cancer treatment I can find

    http://ip.com/patapp/US20090233881

    Compounds having anti-cancer properties (17-Sep-2009)


    US Application Publication (Source: USPTO)
    Publication No. US 2009/0233881 A1 published on 17-Sep-2009
    Application No. US 11/817439 filed on 03-Mar-2006
    Abstract (English)
    There is provided a method for alleviating symptoms, treating or preventing cancer, the method comprising administering to a subject, having or at risk of developing cancer, a pharmaceutical formulation comprising an effective amount of one or more phosphate derivatives of one or more hydroxy chromans selected from the group consisting of 7:8 dimethyl 6 hydroxy chromans, 8 methyl 6 hydroxy chromans and mixtures thereof.
    Inventors/Applicants
    West, Simon Michael [+2] [-2]
    Victoria, AU
    Ogru, Esra
    Victoria, AU
    Gianello, Robert
    Victoria, AU
    Assignees
    Vital Health Sciences Pty. Ltd
    Melbourne, Victoria, AU
    Priority
    AU 2005 901014 03-Mar-2005 [+1] [-1]
    AU 2005 904735 30-Aug-2005
    Classifications
    International (2006.01): A61K 31/66
    National: 514/75
    PCT Filing
    Filed: WO PCT/AU2006/000280 00 03-Mar-2006
    US 371 (c)(1)(2)(4) Date: 10-Nov-2008








 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $3.154M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
15 22549761 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 6667090 8
View Market Depth
Last trade - 16.12pm 03/04/2020 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.